You are here

  • Home
  • Archive
  • Volume 6, Issue 3
  • Review: misoprostol, double dose H2 receptor antagonists, and proton pump inhibitors reduce GI ulcers in long term NSAID use

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: misoprostol, double dose H2 receptor antagonists, and proton pump inhibitors reduce GI ulcers in long term NSAID use

https://doi.org/10.1136/ebm.6.3.88

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2000) Cochrane Database Syst Rev 2000;(4):CD002296 (latest version 21 Aug 2000) (also published in J Rheumatol 27, 2203; Rostom A, Wells G, Tugwell P, et al.. Prevention of NSAID–induced gastroduodenal ulcers.. ;. :. –14).

    
 
 QUESTION: In patients requiring long term non-steroidal anti-inflammatory drugs (NSAIDs), are prostaglandin analogues (PAs), H2 receptor antagonists (H2RAs), and proton pump inhibitors (PPIs) effective at reducing NSAID induced gastrointestinal (GI) ulcers?

    Data sources

    Studies were identified by searching Medline (1966 to January 2000) and EMBASE/Excerpta Medica (to February 1999), the Cochrane Controlled Trials Register (1973–99), current contents (6 mo before January 2000), and conference proceedings; by reviewing bibliographies of retrieved studies, including reviews; and through personal contact with experts and companies.

    Study selection

    2 reviewers independently selected randomised controlled trials published in any language. Studies were selected if they examined PA, H2RA, or PPI effects on preventing NSAID induced upper GI toxicity in adults; if the duration of NSAID exposure was >3 weeks; and if endoscopic ulcers were ≥3 mm in …

    View Full Text

    Footnotes

    • ↵‡ NNT and CI calculated from data in reference 1.

    Footnotes

    • Source of funding: no external funding.

    • For correspondence: Dr A Rostom, Division of Gastroenterology, Ottawa Hospital-Civic Site, 1053 Carling Avenue, Ottawa, Ontario K1Y 4E9, Canada. Fax +1 613 761 5068.